利福霉素,3-氨基-1,4-二脱氧-1,4-二氢-4-亚氨基-1-氧代-，CAS 登记号 62041-01-4，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 利福霉素,3-氨基-1,4-二脱氧-1,4-二氢-4-亚氨基-1-氧代- 的 CAS 号：62041-01-4，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Rifamycin,3-amino-1,4-dideoxy-1,4-dihydro-4-imino-1-oxo- · CAS 62041-01-4 · C37H47N3O11. UNII NK7M8T0JI2.
| CAS Registry Number | 62041-01-4 |
|---|---|
| PubChem CID | 9575738 |
| Molecular formula | C37H47N3O11 |
| IUPAC name | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26,27-diamino-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,29-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,24,26-octaen-13-yl] acetate |
| UNII (FDA) | NK7M8T0JI2 |
| Molecular Weight | 709.8 |
|---|---|
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 3 |
| Exact Mass | 709.32105932 |
| Monoisotopic Mass | 709.32105932 |
| Topological Polar Surface Area | 230 |
| Heavy Atom Count | 51 |
| Formal Charge | 0 |
| Reported hazard statements | H319 (100%), H412 (100%) |
|---|
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H412 (100%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
NK7M8T0JI2; 3-Amino-4-imidorifamycin S; Rifabutin impurity D [EP]; 3-Amino-4-deoxo-4-iminorifamycin S; Rifamycin, 3-amino-1,4-dideoxy-1,4-dihydro-4-imino-1-oxo-; RIFABUTIN IMPURITY D [EP IMPURITY]; 3-Amino-1,4-dideoxy-1,4-dihydro-4-imino-1-oxorifamycin; RIFABUTIN IMPURITY D (EP IMPURITY); Rifabutin impurity D; RefChem:497265; DTXCID601842069; 612-936-2; 62041-01-4; DTXSID501021121; UNII-NK7M8T0JI2; 3-Amino-4-deoxo-4-imino-rifamycin S
CAS 62041-01-4; molecular formula C37H47N3O11; molecular weight — g/mol.
NK7M8T0JI2, 3-Amino-4-imidorifamycin S, Rifabutin impurity D [EP], 3-Amino-4-deoxo-4-iminorifamycin S, Rifamycin, 3-amino-1,4-dideoxy-1,4-dihydro-4-imino-1-oxo-, RIFABUTIN IMPURITY D [EP IMPURITY].
Hazard statements reported: H319, H412.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.